Monday, April 15, 2019 7:36:20 AM
Recruited to Guided Therapeutics in January, 2014
24 years at Abbott Diagnostics
Over 30 years of experience working in the IVD diagnostics industry
GM of Hematology business
GM of Molecular Diagnostics business
VP of Marketing for Diagnostics ($3B) for 5 years
Recruited to GE as President Molecular Diagnostics
Spun out GE JV (Omnyx, LLC), Founder and CEO for 5 years
PhD in Chemistry Stanford, MBA Northwestern
This why GENE/Genius Need to reach out to NOT ORANGES
2. Not oranges have every woman numbers saved in their database World wide
3. Not oranges is venturing into diagnostic low risk business with a Watch
4. Not oranges watch is definitive gesture of exploring into Diagnostic world
5. GTHP Uses light for detection. Not oranges are masters of GLASS /Light technology
6. 3M For FDA approval is pennies for not oranges check written to GENE in exchanges of 8M share out of 16M max
7. Not oranges have/has ready to go MASSIVE Production line ready to go...
8. Share holders pressure Gene to call NOT oranges Today yyyyyyyyyyyyy
5000USD/Share….
https://www.worldcoinindex.com/coin/crypterium
Recent GTHP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 06:36:25 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/20/2024 06:42:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:48:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 04:24:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 09:49:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2023 04:44:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/07/2023 07:53:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 07:00:31 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM